Patent 7166762 was granted and assigned to Takeda Pharmaceutical Company on January, 2007 by the United States Patent and Trademark Office.
A non-human mammal which is usefully and effectively applicable to the screening of a substance to be employed for preventing and treating heart failure. This animal is an animal model of heart failure prepared by starting both coronary stenosis and the stenosis of arteries other than the coronary artery and the abdominal artery of a non-human mammal within the same period of time.